Fatima Cardoso is the Director of the Breast Unit of the Champalimaud Clinical Cancer in Lisbon. Dr Cardoso earned her medical degree at the University of Porto and completed fellowships in the Translational Research Unit of the Jules Bordet Institute (IJB) in Brussels, Belgium, and the Department of Molecular and Cellular Oncology at MD Anderson Cancer Center in Houston, Texas. She then worked for 10 years as Assistant Professor at the Medical Oncology Clinic of the IJB where, besides her clinical work, she was active in the Translational Research Unit and was responsible for phase II-III trials in breast cancer. She is actively involved in a number of phase I-III breast cancer clinical trials and served as the scientific director of the international research network TRANSBIG for 7 years (EU Framework VI).
She is board certified in medical oncology and internal medicine. Dr Cardoso’s research interests include biology of breast cancer, prognostic and predictive markers of response to systemic therapy, and new anticancer agents. Dr Cardoso is actively involved in numerous professional organizations such as ESMO – European Society for Medical Oncology (member of Board of Directors and Chair of the National Representatives Committee), EORTC – European Organization for Research and Treatment of Cancer (Board of Directors & Chair EORTC-Breast Group), ASCO – American Society of Clinical Oncology (International Affairs Committee and Breast Cancer Guideline Advisory Group) and ESO – European School of Oncology (Breast Cancer Program Coordinator) as well as chair of the Advanced Breast Cancer International Consensus Guidelines Conference (ABC). Dr Cardoso is editor-in-chief of The Breast Journal, associate editor of the European Journal of Cancer, and an editorial board member of several other journals.